Echtzeit-Aktienkurs Solana Company
Bid:
Ask:
Echtzeit-Chart der Solana Company Aktie
Fundamentaldaten der Solana Company Aktie
Income Statement: 10-Year-Summary
Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
---|---|---|---|---|---|---|---|
2019 [USD] | 1,50 Mio. | -9,78 Mio. | -9,78 Mio. | -0,37 | - | - | - |
2018 [USD] | 0,48 Mio. | -28,62 Mio. | -28,62 Mio. | -1,26 | - | - | - |
2017 [USD] | - | -28,02 Mio. | -28,02 Mio. | -1,50 | - | - | - |
2016 [USD] | - | -6,88 Mio. | -6,88 Mio. | -0,60 | - | - | - |
2015 [USD] | - | -9,84 Mio. | -9,84 Mio. | -0,85 | - | - | - |
Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der Solana Company Aktie
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.